Across 45 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by 이환철, Executive. Director active across 2 companies, notably 엘앤씨바이오. In total, 64 filings have been logged. Activity tracked since 29 August 2025. The latest transaction was disclosed on 29 August 2025 (Purchase). Regulator: DART (FSS). The full history is free.
Lee Hwan-cheol is an executive at L&C Bio. In his role, he is involved in managing the operations and projects of the company. L&C Bio specializes in the biopharmaceutical sector. Lee Hwan-cheol contributes to the efficiency and performance of the company.